Xinyuan Max Ma

Company: Burning Rock Dx

Job title: Translational Medicine Scientist

Seminars:

High Quality NGS Techniques for ctDNA Biomarker Detection in Clinical Trials 12:15 pm

• Pre-analytical considerations of ctDNA application in Oncology • FDA-lead SEQC2 study, published on Nature Biotechnology April 2021, provides a reliable basis for clinical experts to select high-quality NGS for the first time, and a referable technical standard for clinical application and large clinical trials of early and advanced cancer patients • ctDNA-based biomarker detection…Read more

day: Day One